CSIMarket
 
Bright Minds Biosciences Inc   (DRUG)
Other Ticker:  
 

Bright Minds Biosciences Inc

Officers & Directors






  News about Bright Minds Biosciences Inc Key Personnel

Bright Minds Biosciences Seeks Redemption with $35 Million Fundraising Amidst Financial Turmoil and Competitive Pressure,

Bright Minds Biosciences: A $35 Million Gamble Amidst Dismal Financials and Industry CompetitionIn an audacious move that has raised eyebrows among investors and market analysts alike, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has closed a non-brokered private placement, securing $35 million by selling 1,612,902 common shares at a price of $21.70 each. The announcement, made on November 4, 2024, marks a significant financial maneuver for the Vancouver-based biotech company, especially considering its recent performance and the fiercely competitive landscape it faces.This considerable influx of cash comes on the heels of the company reporting a cumulative net loss of $6 million during the 12 mo...






DRUG Management Effectiveness DRUG Revenue per Employee DRUG Income per Employee


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com